Lataa...
Adoptive Cell Therapies for Glioblastoma
Glioblastoma (GBM) is the most common and most aggressive primary brain malignancy and, as it stands, is virtually incurable. With the current standard of care, maximum feasible surgical resection followed by radical radiotherapy and adjuvant temozolomide, survival rates are at a median of 14.6 mont...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3823029/ https://ncbi.nlm.nih.gov/pubmed/24273748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2013.00275 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|